Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 16 Mar 2026 for Myriad Genetics INC.
Filing timeline
BuySaleSamraat S. Raha
Insider track record
Disclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-14.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Samraat S. Raha: trading record in brief
Samraat S. Raha has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Agilent Technologies, Inc. and Myriad Genetics Inc. Over a trading history stretching from 15 May 2018 to 14 March 2026, the count stands at 60 filings.
In open-market terms, that means 1 purchase worth €173k on one side and 1 sale worth €109k on the other. Taken together, the purchases exceed the sales by €65k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 58 share grants. 2026 to date brings 1 purchase and no sales.
The record was last updated on 16 March 2026 with a share grant (€44k) in Myriad Genetics Inc. The latest purchase dates back some time: it was published 229 days ago, on 9 March 2026. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Samraat S. Raha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
618,557 shares0Common StockSEC:0001738340-26-000004:0
40,000 shares@ US$4.996122.1% of flowCommon StockSEC:0001738340-26-000002:0
Canonical exit: 7 Jun 2026 (T+90)
29,634 shares@ US$7.3030.2% of flowCommon StockSEC:0001738340-25-000009:0
1,498 shares@ US$3.5621.1% of flowCommon StockSEC:0001738340-25-000006:0
216,495 shares0Common StockSEC:0001628280-25-013141:0
29,578 shares@ US$14.5196.5% of flowCommon StockSEC:0001738340-24-000004:0
1,118 shares@ US$13.833.5% of flowCommon StockSEC:0001738340-24-000002:0
64,494 shares0Common StockSEC:0001628280-24-011680:0
236,360 shares0Common StockSEC:0001738340-23-000006:0
11,225 shares@ US$111.6117.3% of flowCommon StockSEC:0001127602-23-028439:0
345 shares@ US$114.190.5% of flowCommon StockSEC:0001127602-23-027951:0
1,578 shares@ US$113.152.4% of flowCommon StockSEC:0001127602-23-028021:0
11,225 shares@ US$111.6117.3% of flowCommon StockSEC:0001127602-23-027714:0
428 shares@ US$113.600.7% of flowCommon StockSEC:0001127602-23-027752:0
1,120 shares@ US$146.192.3% of flowCommon StockSEC:0001127602-22-026144:0
457 shares@ US$144.440.9% of flowCommon StockSEC:0001127602-22-026123:0
344 shares@ US$147.120.7% of flowCommon StockSEC:0001127602-22-026024:0
3,453 shares@ US$148.007.3% of flowCommon StockSEC:0001127602-22-025887:0
737 shares@ US$148.311.6% of flowCommon StockSEC:0001127602-22-025645:0
226 shares@ US$119.380.0001% mcap0.8% of flowCommon StockSEC:0001127602-22-014730:0
2,774 shares@ US$161.390.0012% mcap11.8% of flowCommon StockSEC:0001127602-22-003070:0
2,774 shares@ US$161.390.0012% mcap11.8% of flowCommon StockSEC:0001127602-21-031207:0
1,121 shares@ US$164.305.1% of flowCommon StockSEC:0000899243-21-045726:0
457 shares@ US$161.542.1% of flowCommon StockSEC:0001127602-21-029672:0
2,774 shares@ US$161.3912.4% of flowCommon StockSEC:0001127602-21-029625:0
25 of 27 declarations
